FDA Investigator David A Trent Carlson
David A Trent Carlson has conducted inspections on 39 sites in 2 countries as of 17 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
39
Last Inspection Date:
17 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Sweden,
United States of America
FDA Investigators that have inspected at least one site in common with David A Trent Carlson:
Afaaf G Nassif,
Alissa E Berryman,
Alois P Provost,
Althea A Williams,
Ann B Okon,
Anne E Carpenter,
Anthony N Onianwa,
Anthony R Rauert,
Anthony W Thomas,
Bruce G Cooper,
Charlean R Butler,
Christine M O'leary,
Daniel L Aisen,
Daryl D Javellana,
David A Carlson,
Dipesh K Shah,
Douglas S Joslin,
Eduardo L Rodriguez,
Elizabeth H Davis,
Elizabeth H Slazak,
Erin L Nagel,
Esaw,
Gifford Whitehurst, Jr,
Harry J Brewer,
Hien Albright,
Hilary K Wagner,
Jamie R Thompson,
Jason Kwong,
Jeffrey A Reed,
Joel R Merriman,
John A Hollings,
John Dan,
Joseph H Procopio, Jr,
Joseph Milcetic,
Joy P Matthias,
Judy Keihl,
Justin C Fuller,
Karen L Kosar,
Kenneth G Klobus,
Kenneth L Smalls,
Kimberley A Ricketts,
Kimberly Y Smithson,
Latoya S Oliver Powell,
LCDR Wilfred A Darang,
Linda M Sacco,
Marc S Neubauer,
Marlene L Davis,
Maryam Tabatabaie,
Matthew D Schnittker,
Michael A Charles,
Michael W Burd,
Myra L Gemmill,
Nicholas J Morici,
Nichole B Murphy,
Pelekakis,
Perez,
Rachael A Moss,
Raymond M Lam,
Rita F Monfort,
Sean R Moynihan, MPH,
Seemay A Lee,
Sierra M Shockley,
Slater K Bartlett,
Stephanie M Roberts Pedotti,
Stephen C Eason,
Stephen C King,
Tamara N Champion,
Thomas J Hudson,
Todd D Alspach,
Weston K Szymanski,
William C Lubas,
William V Thompson
David A Trent Carlson's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2013 | FDA 483 | Ivoclar Vivadent, Inc. - Form 483, 2013-06-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more